News
The Air Force has issued guidance on how transgender Airmen and Guardians will be involuntarily discharged, making it the ...
20h
Clinical Trials Arena on MSNAdvancing rare disease trials by overcoming patient recruitment challenges
The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark ...
When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...
The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died ...
More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.
Michela Cimberle, senior staff writer for Healio | OSN, won an APEX Award of Excellence for a 2024 exclusive story on diversity in clinical trials and efforts to improve health equality. Cimberle ...
A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing on MRIs after the breakthrough cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results